 |
5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin |
|---|---|
| Trade Name | |
| Orphan Indication | Biliary tract cancer |
| EU Market Approval | EU |
| EU Designation Date | 2015-03-19 00:00:00 |
| Sponsor | Luzitin S.A |
| |
5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin |
|---|---|
| Trade Name | |
| Orphan Indication | Biliary tract cancer |
| EU Market Approval | EU |
| EU Designation Date | 2015-03-19 00:00:00 |
| Sponsor | Luzitin S.A |